ICML 2021 | Advancements in peripheral T cell lymphoma
Stefano Luminari
• 23 Jun 2021
Stefano Luminari, MD, University of Modena and Reggio Emilia, Emilia-Romagna, Italy analyzes new trends within peripheral T cell lymphoma (PTCL). Assessing the cell of origin and cell type has improved diagnosis of PTCL, where treatments for patients can be subsequently optimized. Certain subtypes respond better particular treatments; neoplastic lymphomas responds better to brentuximab vedotin whereas epigenetic modifiers are better suited for T follicular helper cell lymphoma. More cooperation is required to gather sufficient data to develop novel therapies. This interview took place during the 2021 International Conference on Malignant Lymphoma (16-ICML).
